EODData

NASDAQ, PLRX: Pliant Therapeutics Inc

07 Nov 25 15:59
LAST:

1.600

CHANGE:
 0.07
OPEN:
1.500
HIGH:
1.620
ASK:
0.000
VOLUME:
914.4K
CHG(%):
4.58
PREV:
1.530
LOW:
1.450
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.5101.6201.4501.6001.01M
06 Nov 251.6401.6551.5151.5301.16M
05 Nov 251.6101.7201.5801.6401.21M
04 Nov 251.6201.6601.5801.610442.7K
03 Nov 251.6701.7301.6401.670291.5K
31 Oct 251.6301.7301.6101.680530.9K
30 Oct 251.7301.7501.6301.640310.4K
29 Oct 251.7801.8051.7101.740596.0K
28 Oct 251.7901.8301.7101.780628.4K
27 Oct 251.8101.9501.7601.8001.09M

COMPANY PROFILE

Name:Pliant Therapeutics Inc
About:Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Website:https://pliantrx.com
CUSIP:727049405
CIK:0001746473
ISIN:US7291391057
FIGI:BBG00C8083N4
LEI:5493002Q5LITR7VHZH02

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.48 
Forward P/E:-0.42 
PEG Ratio:0.02 
Price to Sales:3,071.82 
Price to Book:0.47 
Return on Assets:-0.35 
Return on Equity:-0.68 
EPS Ratio:-3.38 
Shares:61.39M 
Market Cap:98.22M 

TECHNICAL INDICATORS

MA5:1.610.6%
MA10:1.674.3%
MA20:1.674.3%
MA50:1.600.1%
MA100:1.534.4%
MA200:2.0326.9%
STO9:23.33
STO14:16.67 
RSI14:47.78
WPR14:-79.41
MTM14:-0.27
ROC14:-0.14 
ATR:0.14 
Week High:1.738.1%
Week Low:1.4510.3%
Month High:1.9521.9%
Month Low:1.4526.9%
Year High:15.88892.5%
Year Low:1.1045.4%